Effect of black raspberry extract in inhibiting NF B dependent radioprotection in human breast cancer cells

Nutrition and Cancer

Volumn 62, Issue 1, 2010, Pages 93-104

  Madhusoodhanan, Rakhesh ^a   Natarajan, Mohan ^b   Singh, Jamunarani Veeraraghavan Nisha ^a   Jamgade, Ambarish ^a   Awasthi, Vibhudutta ^a   Anant, Shrikant ^a   Herman, Terence S ^a   Aravindan, Natarajan ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERLEUKIN 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; PLANT EXTRACT; RADIOSENSITIZING AGENT; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; BINDING AFFINITY; BREAST ADENOCARCINOMA; CANCER CELL; CELL DEATH; CELL STRAIN MCF 7; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIATION PROTECTION; RASPBERRY;

APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; FRUIT; GAMMA RAYS; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTERLEUKIN-1ALPHA; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; PHENOLS; PLANT EXTRACTS; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; ROSACEAE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

RUBUS OCCIDENTALIS;

EID: 74249120610     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903191494     Document Type: Article

References (70)

1. Kung HC, Hoyert DL, Xu J, and Murphy SL: Deaths: final data for 2005. Natl Vital Stat Rep 56, 1-120, 2008.
2. Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, et al.: Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 67, 3845-3852, 2007.
3. Morgan WF: Is there a commonmechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionizing radiation? Oncogene 22, 7094-7099, 2003.
4. Cháng HJ,Maj JG, Paris F, Xing HR, Zhang J, et al.: ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med 11, 484-490, 2005.
5. Dewey WC, Ling CC, and Meyn RE: Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33, 781-796, 1995.
6. Jameel JK, Rao VS, Cawkwell L, and Drew PJ: Radioresistance in carcinoma of the breast. Breast 13, 452-460, 2004.
7. Ahmed KM, Dong S, FanM, and Li JJ: Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol Cancer Res 4, 945-955, 2006.
8. Baeuerle PA and Baltimore D: Hormonal control regulation of gene transcription. In: Molecular Aspects of Cellular Regulation, Cohen P and Foulkes JG (eds.). Amsterdam: Elsevier/North Holland Biomedical Press, 1991, pp. 409-432.
9. Lenardo MJ and Baltimore D: NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229, 1989.
10. Sun Z and Andersson R: NF-kappa B activation and inhibition: a review. Shock 18, 99-106. 2002.
11. AhmedKMand Li JJ: NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med 44, 1-13, 2008.
12. Shan YX, Jin SZ, Liu XD, Liu Y, and Liu SZ: Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat Environ Biophys 46, 21-29, 2007.
13. Liu Y, Nakahara T,Miyakoshi J, Hu DL, Nakane A, et al.: Nuclear accumulation and activation of nuclear factor kappa B after split-dose irradiation in LS174T cells. J Radiat Res (Tokyo) 48, 13-20, 2007.
14. Cheng JC, Chou CH, Kuo ML, and Hsieh CY: Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappa B signal transduction pathway. Oncogene 25, 7009-7018, 2006.
15. Sun Y, St Clair DK, Fang F, Warren GW, Rangnekar VM, et al.: The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaBinhibition and enhanced by the presence of PTEN. Mol Cancer Ther 6, 2477-2486, 2007.
16. He L, Kim BY, Kim KA, Kwon O, Kim SO, et al.: NF-kappa B inhibition enhances caspase-3 degradation of Akt1 and apoptosis in response to camptothecin. Cell Signal 19, 1713-1721, 2007.
17. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, et al.: Genistein inhibits radiation-induced activation of NF-kappa B in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6, 107, 2006.
18. Magne N, Toillon RA, Bottero V, Didelot C, Houtte PV, et al.: NF-kappa B modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 231, 158-168, 2006.
19. KimBY, Kim KA,Kwon O, Kim SO, KimMS, et al.: NF-kappaBinhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation. Carcinogenesis 26, 1395-1403, 2005.
20. Aravindan N, Madhusoodhanan R, Ahmad S, Johnson D, and Herman TS: Curcumin inhibits NFkappa B mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 7, 569-576, 2008.
21. AravindanN,MadhusoodhananR,Natarajan M, andHermanTS: Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells. Mol Cell Biochem 310, 167-179, 2008.
22. Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, et al.: Activation of nuclear factor kappa B in radioresistance of TP53-inactive human keratinocytes. Cancer Res 62, 1213-1221, 2002.
23. Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, et al.: Principles of chemoradiation: theoretical and practical considerations. Oncology (Williston Park) 13, 11-22, 1999.
24. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, et al.: Inhibition of JNK activation through NF-kappa B target genes. Nature 414, 313-317, 2001.
25. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421, 2006.
26. Garg AK, Buchholz TA, and Aggarwal BB: Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 7, 1630-1647, 2005.
27. Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, et al.: Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem 54, 9329-9339, 2006.
28. Wang SY and Lin HS: Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage. J Agric Food Chem 48, 140-146, 2000.
29. Wang SY and Jiao H: Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J Agric Food Chem 48, 5677-5684, 2000.
30. Huang C, Huang Y, Li J, HuW, Aziz R, et al.: Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res 62, 6857-6863, 2002.
31. Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, et al.: Inhibition of cellular transformation by berry extracts. Carcinogenesis 22, 351-356, 2001.
32. Li J, Zhang D, Stoner GD, and Huang C: Differential effects of black raspberry and strawberry extracts on BaPDE-induced activation of transcription factors and their target genes. Mol Carcinog 47, 286-294, 2008.
33. Lu H, Li J, Zhang D, Stoner GD, and Huang C: Molecular mechanisms involved in chemoprevention of black raspberry extracts: from transcription factors to their target genes. Nutr Cancer 54, 69-78, 2006.
34. Natarajan M, Aravindan N, Meltz ML, and Herman TS: Post-translational modification of I-kappa B alpha activates NF-kappa B in human monocytes exposed to 56Fe ions. Radiat Environ Biophys 41, 139-144, 2002.
35. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, et al.: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 67, 1075-1087, 1991.
36. Yeoh A, Gibson R, Yeoh E, Bowen J, Stringer A, et al.: Radiation therapy-induced mucositis: relationships between fractionated radiation, NF-kappaB, COX-1, and COX-2. Cancer Treat Rev 32, 645-651, 2006.
37. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, et al.: Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 90, 9901-9905, 1993.
38. Tozawa K, Sakurada S, Kohri K, and Okamoto T: Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res 55, 4162-4167, 1995.
39. Brach MA,Hass R, ShermanML, GunjiH,Weichselbaum R, et al.: Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest 88, 691-695, 1991.
40. Rodrigo KA, Rawal Y, Renner RJ, Schwartz SJ, Tian Q, et al.: Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer 54, 58-68, 2006.
41. Cao C, Mu Y, Hallahan DE, and Lu B: XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 23, 7047-7052, 2004.
42. Lu B, Mu Y, Cao C, Zeng F, Schneider S, et al.: Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res 64, 2840-2845, 2004.
43. Rodel C, Haas J, Groth A, Grabenbauer GG, Sauer R, et al.: Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys 55, 1341-1347, 2003.
44. Giagkousiklidis S, Vogler M, Westhoff MA, Kasperczyk H, Debatin KM, et al.: Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res 65, 10502-10513, 2005.
45. Salvesen GS and Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3, 401-410, 2002.
46. Holcik M, Yeh C, Korneluk RG, and Chow T: Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19, 4174-4177, 2000.
47. Nakanishi C and Toi M: Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5, 297-309, 2005.
48. Ravi R and Bedi A: NF-kappa B in cancer-a friend turned foe. Drug Resist Updat 7, 53-67, 2004.
49. Mohan N and Meltz ML: Induction of nuclear factor kappa B after lowdose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat Res 140, 97-104, 1994.
50. Amundson SA, Do KT, and Fornace AJ Jr.: Induction of stress genes by low doses of gamma rays. Radiat Res 152, 225-231, 1999.
51. Osborn L, Kunkel S, and Nabel GJ: Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 86, 2336-2340, 1989.
52. Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, et al.: NF-kappa B regulates IL-1 beta transcription through a consensus NFkappa B binding site and a nonconsensus CRE-like site. J Immunol 153, 712-723, 1994.
53. Collart MA, Baeuerle P, and Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10, 1498-1506, 1990.
54. Ho YS, Howard AJ, and Crapo JD: Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. Am J Respir Cell Mol Biol 4, 278-286, 1991.
55. Guo G, Yan-Sanders Y, Lyn-Cook BD,Wang T, Tamae D, et al.:Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 23, 2362-2378, 2003.
56. Ross HJ, Canada AL, Antoniono RJ, and Redpath JL: High and low dose rate irradiation have opposing effects on cytokine gene expression in human glioblastoma cell lines. Eur J Cancer 33, 144-152, 1997.
57. Konemann S, Bolling T,Malath J, Kolkmeyer A, Janke K, et al.: Time-and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation. Int J Radiat Biol 79, 897-909, 2003.
58. Braunschweiger PG, Basrur V, Santos O, Adessa A, Houdek P, et al.: Radioresistance in murine solid tumors induced by interleukin-1. Radiat Res 145, 150-156, 1996.
59. Dalmau SR, Freitas CS, and Savino W: Radio-and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines. Leuk Res 21, 93-99, 1997.
60. DorieMJ, Bedarida G, and Kallman RF: Protection by interleukin 1 against lung toxicity caused by cyclophosphamide and irradiation. Radiat Res 128, 316-319, 1991.
61. Hancock SL, Chung RT, Cox RS, and Kallman RF: Interleukin 1 beta initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiation. Cancer Res 51, 2280-2285, 1991.
62. Neta R: Modulation of radiation damage by cytokines. Stem Cells 15(2 Suppl), 87-94, 1997.
63. Neta R, Vogel SN, Plocinski JM, Tare NS, Benjamin W, et al.: In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1: the relationship of radioprotection, colony-stimulating factor, and IL-6. Blood 76, 57-62, 1990.
64. Zaghloul MS, Dorie MJ, and Kallman RF: Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor. Int J Radiat Oncol Biol Phys 26, 417-425, 1993.
65. Siemankowski LM, Morreale J, and Briehl MM: Antioxidant defenses in the TNF-treated MCF-7 cells: selective increase in MnSOD. Free Radic Biol Med 26, 919-924, 1999.
66. Wong GH, Elwell JH, Oberley LW, and Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931, 1989.
67. Duttaroy A, Parkes T, Emtage P, Kirby K, Boulianne GL, et al.: The manganese superoxide dismutase gene of Drosophila: structure, expression, and evidence for regulation by MAP kinase. DNA Cell Biol 16, 391-399, 1997.
68. Wan XS, Devalaraja MN, and St. Clair DK: Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol 13, 1127-1136, 1994.
69. Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, et al.: An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 18, 709-722, 1999.
70. Piva R, BelaradoG, and SantoroMG. NF-kappa B: a stress-regulated switch for cell survival. Antioxid Redox Signal 8, 478-486, 2006.